Enhanced γδ T cell-mediated lysis with tribody [(HER2)2xCD16] was also observed at a lower E/T ratio when other HER2-expressing tumor cells such as the esophageal cancer cell line OE33 were used (Figure S5 in Supplementary Material). This evidence concerns the gene ERBB2 and esophageal cancer.